Chronic thromboembolic pulmonary hypertension.

IF 1.2 Q2 MEDICINE, GENERAL & INTERNAL
Tidsskrift for Den Norske Laegeforening Pub Date : 2025-03-18 Print Date: 2025-03-25 DOI:10.4045/tidsskr.24.0508
John-Peder Escobar Kvitting, Håvard Ravnestad, Rune Andersen, Eyvind Gjønnæss, Natasha Moe, Sigurd Birkeland, Morten Svalebjørg, Per Snorre Lingaas, Einar Gude, Lars Gullestad, Kaspar Broch, Arne K Andreassen
{"title":"Chronic thromboembolic pulmonary hypertension.","authors":"John-Peder Escobar Kvitting, Håvard Ravnestad, Rune Andersen, Eyvind Gjønnæss, Natasha Moe, Sigurd Birkeland, Morten Svalebjørg, Per Snorre Lingaas, Einar Gude, Lars Gullestad, Kaspar Broch, Arne K Andreassen","doi":"10.4045/tidsskr.24.0508","DOIUrl":null,"url":null,"abstract":"<p><p>Chronic thromboembolic pulmonary hypertension is a rare complication of pulmonary embolism and entails high morbidity and mortality. The gold standard for treatment is pulmonary endarterectomy, which improves haemodynamics and exercise capacity, and is potentially curative. Alternative options for the approximately one third of patients who are inoperable are percutaneous balloon pulmonary angioplasty and medical therapy. The aim of this article is to provide a clinical overview of the pharmacological, endovascular and surgical treatments for the condition.</p>","PeriodicalId":23123,"journal":{"name":"Tidsskrift for Den Norske Laegeforening","volume":"145 4","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tidsskrift for Den Norske Laegeforening","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4045/tidsskr.24.0508","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/25 0:00:00","PubModel":"Print","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Chronic thromboembolic pulmonary hypertension is a rare complication of pulmonary embolism and entails high morbidity and mortality. The gold standard for treatment is pulmonary endarterectomy, which improves haemodynamics and exercise capacity, and is potentially curative. Alternative options for the approximately one third of patients who are inoperable are percutaneous balloon pulmonary angioplasty and medical therapy. The aim of this article is to provide a clinical overview of the pharmacological, endovascular and surgical treatments for the condition.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Tidsskrift for Den Norske Laegeforening
Tidsskrift for Den Norske Laegeforening MEDICINE, GENERAL & INTERNAL-
CiteScore
0.60
自引率
18.20%
发文量
593
审稿时长
28 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信